Organization
Incyte Corp.
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed
Incyte Corp.
... Networks, Inc. (NYSE:CUDA), Abraxas Petroleum Corporation (NASDAQ:AXAS), Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX), Incyte Corporation (NASDAQ:INCY), Forum Energy Technologies, Inc. (NYSE:FET), and S&P Global Inc. (NYSE:SPGI) including ...
... Incyte Corporation (Nasdaq:INCY) today announced that the first patient has been treated in the ...
... Proceedings. In October 2017, the Patent Trial and Appeal Board (PTAB) denied Incyte's petition to institute inter partes review (IPR) of U.S. Patent No. 9,249,149. ...
... cocktail can hold its own against a combination of rival drugs from Incyte and Merck. IDO1 has emerged as a key battleground in immuno-oncology as ...
... If you want a Stock Review on IMGN, INCY, INFI, or INSM then come over tohttp://dailystocktracker.com/register/and sign up for your free ...
... we continued to advance our clinical program in conjunction with our partners Incyte, Merck, and Dana-Farber Cancer Institute," said Frederic Ors, Immunovaccine's Chief Executive Officer. ...
... December. Finally, we are thrilled to work with our new collaboration partner, Incyte, to expand the current development efforts for MGA012 and accelerate our own ...
... in the third quarter from the company's collaboration and license agreement with Incyte. Research and development expenses were $ 10.8 million for the three months ...
... Galderma) ANB 020 (anti-IL33; AnaptysBio) Upadacitinib (JAK inhibitor; AbbVie) Ruxolitinib (JAK inhibitor; Incyte) PF 04965842 (JAK inhibitor; Pfizer) Baricitinib (JAK inhibitor; Eli Lilly/Incyte) ALX 101 ...
... Eli Lilly and Company (NYSE: LLY) and Incyte Corporation (NASDAQ: INCY) announced today that patients with moderate-to-severe rheumatoid arthritis (RA) treated ...
... in the third quarter from the company's collaboration and license agreement with Incyte. Research and development expenses were $10.8 million for the three months ended ...
... Incyte Corporation (Nasdaq:INCY) announces that more than 30 abstracts including data from its clinical ...
... Incyte Corporation (Nasdaq: INCY) today reports 2017 third-quarter financial results, highlighting 38 percent year-on-year ...
... Incyte Corporation (Nasdaq:INCY) and MedImmune, AstraZeneca's (NYSE:AZN) global biologics research and development arm, today ...
... AstraZeneca has enlisted the aid of Incyte to try to boost its ambitions in a category of lung cancer ...
... 17 abstracts, including six oral presentations on rheumatoid arthritis (RA) (Lilly and Incyte Corporation are partners on the development of baricitinib). Highlights include a new ...
... Incyte Corporation (Nasdaq:INCY) today announced the appointment of Jacqualyn "Jackie" A. Fouse, Ph.D., as ...
... Incyte Corporation (NASDAQ:INCY) and MacroGenics, Inc. (NASDAQ:MGNX) announced today that the companies have entered ...
... Incyte is paying $150 million upfront for worldwide rights to MacroGenics’ PD-1 drug. ...
... Incyte Corporation (Nasdaq:INCY) announced today that it will present at the 26th Annual Credit ...
... Appeal Board (PTAB) of the U.S. Patent and Trademark Office has denied Incyte's petition to institute inter partes review (IPR) of U.S. Patent No. 9,249,149 ...
... her a pill called Jakafi, manufactured by a Wilmington, Delaware, company called Incyte. She felt better in days. After dinner at a restaurant, she insisted ...
... arginase being developed pursuant to a global collaboration and license agreement with Incyte Corporation. 'Arginase is involved in the metabolism of a key amino acid ...
... Appeal Board (PTAB) of the U.S. Patent and Trademark Office has denied Incyte's petition to institute inter partes review (IPR) of U.S. Patent No. 9,249,149 ...
... Company) Courtagen Life Sciences, Inc. Cynvenio Biosystems, Inc. DNA Electronics Ltd. Eurofins Genomics Exosome Diagnostics, Inc. Foundation Medicine, Inc. GATC Biotech AG GenapSys, Inc. GENEWIZ ...
Want to see the full history of news or view news on a particular date? Upgrade to RelSci Professional now!
Start My Free Trial ➤